Vance R. Brown, Senior Vice President, General Counsel, and Corporate Secretary, has demonstrated a clear selling bias in his recent transactions involving Boston Scientific Corporation (BSX), according to SEC Form 4 filings. Over 43 reported trades, Brown has sold approximately $6.07 million worth of BSX shares while purchasing $849,320 worth—a nearly 7-to-1 ratio favoring disposals. His most recent activity includes two sales on February 14 and 16, 2026, totaling $133,393, following a larger $955,946 sale on February 13, 2026. These disposals align with a broader pattern of periodic selling, including two notable transactions in early 2025—$486,702 on March 21 and $504,992 on February 21—while his buys have been smaller and more sporadic, such as a $204,530 acquisition on July 1, 2025.
Brown’s transactions are exclusively tied to BSX, with no activity in other companies. The filings show that his sales often cluster around mid-to-late February, suggesting possible routine dispositions tied to equity compensation or tax planning. While his purchases are less frequent, they tend to be concentrated in similar timeframes, such as a series of smaller acquisitions in February 2025 totaling roughly $285,000. The absence of recent buys—coupled with consistent selling—indicates a continued reduction in his BSX holdings, though the precise reasons remain undisclosed in the filings. The pattern reflects a disciplined approach, with sales executed at varying scales, from five-figure transactions to near-million-dollar disposals.
AI-assisted summary